Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

13.88

-0.04 (-0.29%)

At close: Apr 15, 2025, 4:00 PM

13.84

-0.04 (-0.25%)

After-hours: Apr 15, 2025, 7:55 PM EDT

Mineralys Therapeutics Employees

Mineralys Therapeutics had 51 employees as of December 31, 2024. The number of employees increased by 23 or 82.14% compared to the previous year.

Employees

51

Change (1Y)

23

Growth (1Y)

82.14%

Revenue / Employee

n/a

Profits / Employee

-$3,486,471

Market Cap

898.63M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	51	23	82.14%
Dec 31, 2023	28	16	133.33%
Dec 31, 2022	12	-	-

MLYS News

17 days ago - Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology's Annual Scientific Session & Expo (ACC.25) - GlobeNewsWire
21 days ago - Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET - GlobeNewsWire
4 weeks ago - Mineralys Therapeutics Announces Closing of Underwriters' Option to Purchase Additional Shares in Connection with Public Offering of Common Stock - GlobeNewsWire
4 weeks ago - Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology's Annual Scientific Session & Expo - GlobeNewsWire
4 weeks ago - Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
5 weeks ago - Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
5 weeks ago - Mineralys: Prospects Just Got Better With Successful Pivotal Data Readouts - Seeking Alpha
5 weeks ago - Mineralys Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire